Dominik C Benz
Overview
Explore the profile of Dominik C Benz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
830
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pingree R, Markendorf S, Moysidis D, Ryffel C, Stuetz M, Ghenzi R, et al.
Eur J Nucl Med Mol Imaging
. 2025 Mar;
PMID: 40082264
Purpose: To determine the most important patient factors influencing quantitative MBF and to report the lower (LRL) and upper (URL) reference limits for 13N-ammonia positron emission tomography (PET) myocardial perfusion...
2.
Heiniger P, Igual G, Galafton A, Albertini T, Gajic M, Jurisic S, et al.
J Nucl Cardiol
. 2025 Mar;
:102172.
PMID: 40032238
Background: The influence of fibrosis transmurality and location on the diagnostic performance of positron emission tomography (PET) myocardial perfusion imaging (MPI) for detecting myocardial fibrosis remains unclear. Methods And Results:...
3.
Benz D, Sadeghi A, Rafter P, Clerc O, Canseco Neri J, Taylor A, et al.
Circ Cardiovasc Imaging
. 2025 Mar;
:e017475.
PMID: 40026172
Background: Noninvasive tools to measure myocardial stiffness are limited. Intrinsic cardiac elastography in echocardiography relates to myocardial stiffness by measuring the propagation of the myocardial stretch generated by atrial contraction....
4.
5.
Laptseva N, Benz D, Schwotzer R, Flammer A
Swiss Med Wkly
. 2024 Nov;
154:4186.
PMID: 39571050
Cardiac amyloidosis is a disease characterised by the accumulation of amyloid protein in the heart tissue. There are several types of amyloidosis, but the most common types affecting the heart...
6.
Clerc O, Vijayakumar S, Cuddy S, Bianchi G, Canseco Neri J, Taylor A, et al.
JACC Heart Fail
. 2024 Sep;
12(12):1994-2006.
PMID: 39243245
Background: In light-chain (AL) amyloidosis, whether functional status and heart failure-related quality of life (HF-QOL) correlate with cardiomyopathy severity, improve with therapy, and are associated with major adverse cardiac events...
7.
Kovacs B, Gllareva V, Ruschitzka F, Duru F, Kaufmann P, Buechel R, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Aug;
26(1):30-37.
PMID: 39213366
Aims: Known predictors of major arrhythmic events (MAEs) in patients with ischaemic cardiomyopathy (ICM) include previous MAE and left ventricular ejection fraction (LVEF) ≤ 35%. Myocardial scars detected by perfusion...
8.
Gajic M, Galafton A, Heiniger P, Albertini T, Jurisic S, Gebhard C, et al.
Int J Cardiovasc Imaging
. 2024 Aug;
40(10):2203-2212.
PMID: 39102075
This study aimed to evaluate the impact of acute intravenous beta-blocker administration on myocardial blood flow (MBF) during same-day hybrid coronary computed tomography angiography (CCTA) and 13N-ammonia positron emission tomography...
9.
Clerc O, Cuddy S, Jerosch-Herold M, Benz D, Katznelson E, Canseco Neri J, et al.
JACC Cardiovasc Imaging
. 2024 Jul;
17(11):1271-1286.
PMID: 39001736
Background: In systemic light-chain (AL) amyloidosis, cardiac involvement portends poor outcomes. Objectives: The authors' objectives were to detect early myocardial alterations, to analyze longitudinal changes with therapy, and to predict...
10.
Clerc O, Datar Y, Cuddy S, Bianchi G, Taylor A, Benz D, et al.
JACC Cardiovasc Imaging
. 2024 Jul;
17(8):911-922.
PMID: 39001731
Background: Positron emission tomography/computed tomography (PET/CT) with F-florbetapir, a novel amyloid-targeting radiotracer, can quantify left ventricular (LV) amyloid burden in systemic light-chain (AL) amyloidosis. However, its prognostic value is not...